development risk

  2. development risk

CLINICAL CASE: SYNCHRONOUS MALIGNANCY: LEFT BREAST AND OVARIAN CANCER ASSOCIATED WITH HEREDITARY BRCA1: 5382 INS C – MUTATION

Kravchenko O. V., Bashtan O. P., Chornobai A. V., Mukovoz O. E., Hahal O. V.
2023 Issue 2, 169 BRCA 1\2 mutation breast cancer development risk heredity ovarian cancer